sy-5609,gemcitabine,paclitaxel
syros
['sy-5609', 'solid tumor', 'paclitaxel', 'gemcitabine', 'pancreatic']
hall a | sat 8am ct
phase 1/1b study of sy-5609, a selective and potent cdk7 inhibitor, in advanced solid tumors and in 2l/3l pancreatic ductal adenocarcinoma (pdac) in combination with gemcitabine +/- nab-paclitaxel
dejan juric, md #mgccatasco23
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.